The liver sinusoid, mainly composed of liver sinusoidal endothelial cells, hepatic macrophages and hepatic stellate cells, shapes the hepatic vasculature and is key to maintaining liver homeostasis and function. During chronic liver disease (CLD), the function of sinusoidal cells is impaired, being directly involved in the progression of liver fibrosis, cirrhosis, and main clinical complications including portal hypertension and hepatocellular carcinoma. In addition to their roles in liver diseases pathobiology, sinusoidal cells’ paracrine communication or cross-talk is being studied as a mechanism of disease but also as a remarkable target for treatment. The aim of this review is to gather current knowledge of intercellular signalling in the hepatic sinusoid during the progression of liver disease. We summarise studies developed in pre-clinical models of CLD, especially emphasizing those pathways characterized in human-based clinically relevant models. Finally, we describe pharmacological treatments targeting sinusoidal communication as promising options to treat CLD and its clinical complications.
Citations
Citations to this article as recorded by
Regression of fibrosis and portal hypertension in chronic liver disease: Endothelial perspectives and clinical implications Yuly P Mendoza, Raül Pastó, Sonia E Selicean, Jordi Gracia-Sancho Annals of Hepatology.2026; : 102174. CrossRef
LSEC-derived CXCL9 orchestrates immune recruitment and hepatocyte reprogramming in liver fibrosis Jing Li, Qiannan Di, Xiujuan Zhou, Mengling Chang, Wei Chen Acta Biochimica et Biophysica Sinica.2026;[Epub] CrossRef
Nodular Transformation–driven Circulatory Remodeling in Biliary Atresia–induced Pediatric Biliary Cirrhosis: A Three-dimensional Phase-Contrast CT Rendering Bei-Ning Qi, Xin-Yan Zhao, Wen-Juan Lv, Shan Shan, Xian-qin Du, Jian-Bo Jian, Chun-Hong Hu Radiology.2026;[Epub] CrossRef
Vasomics of the liver Chengyan Wang, Eric Felli, Jonathan Andrew Fallowfield, Christoph Frank Dietrich, Don Rockey, Jürgen Hennig, Gao-Jun Teng, Jordi Gracia-Sancho, Xiaolong Qi Gut.2025; 74(6): 1008. CrossRef
Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells Enis Kostallari, Robert F. Schwabe, Adrien Guillot Cellular & Molecular Immunology.2025; 22(10): 1205. CrossRef
The pathophysiological role of portal hypertension in metabolic dysfunction–associated steatotic liver disease Søren Møller, Sannia M.S. Sjöstedt, Lise Hobolth, Christian Mortensen, Nina Kimer Hepatology Communications.2025;[Epub] CrossRef
Hepatocyte-derived extracellular vesicles promote endothelial dedifferentiation in chronic liver disease through the miR-153-3p-pyroptosis axis Laia Abad-Jordà, María Andrés-Rozas, Ana Martínez-Alcocer, Jessica Aspas, Yiliam Fundora, Sonia Fernández-Veledo, Carmen Peralta, Sergi Guixé-Muntet, Anabel Fernández-Iglesias, Jordi Gracia-Sancho Hepatology.2025;[Epub] CrossRef
Hepatic Fibrosis and Liver Cancer Aina Anton, Scott L. Friedman, Bruno Cogliati Seminars in Liver Disease.2025;[Epub] CrossRef
Correspondence on Letter regarding “Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances” Byoung Kuk Jang Clinical and Molecular Hepatology.2024; 30(2): 297. CrossRef
Background/Aims Cholestatic liver diseases including primary biliary cholangitis (PBC) are associated with active hepatic fibrogenesis, which ultimately progresses to cirrhosis. Activated hepatic stellate cells (HSCs) are the main fibrogenic effectors in response to cholangiocyte damage. JCAD regulates cell proliferation and malignant transformation in nonalcoholic steatoheaptitis-associated hepatocellular carcinoma (NASH-HCC). However, its participation in cholestatic fibrosis has not been explored yet.
Methods Serial sections of liver tissue of PBC patients were stained with immunofluorescence. Hepatic fibrosis was induced by bile duct ligation (BDL) in wild-type (WT), global JCAD knockout mice (JCAD-KO) and HSC-specific JCAD knockout mice (HSC-JCAD-KO), and evaluated by histopathology and biochemical tests. In situ-activated HSCs isolated from BDL mice were used to determine effects of JCAD on HSC activation.
Result s: In consistence with staining of liver sections from PBC patients, immunofluorescent staining revealed that JCAD expression was identified in smooth muscle α-actin (α-SMA)-positive fibroblast-like cells and was significantly up-regulated in WT mice with BDL. JCAD deficiency remarkably ameliorated BDL-induced hepatic injury and fibrosis, as documented by liver hydroxyproline content, when compared to WT mice with BDL. Histopathologically, collagen deposition was dramatically reduced in both JCAD-KO and HSC-JCAD-KO mice compared to WT mice, as visualized by Trichrome staining and semi-quantitative scores. Moreover, JCAD deprivation significantly attenuated in situ HSC activation and reduced expression of fibrotic genes after BDL.
Conclusions JCAD deficiency effectively suppressed hepatic fibrosis induced by BDL in mice, and the underlying mechanisms are largely through suppressed Hippo-YAP signaling activity in HSCs.
Citations
Citations to this article as recorded by
Features and functional mechanisms of super-enhancers in cardiovascular disorders, cancer, autoimmune diseases and neurodegenerative disorders Zi-Rong Li, Yong-Yan Wang, Chao Zhang, Jin-Sha Shi, Xiao Yu, Ni-Tong Ying, Xiao-Ke Xu, Juan-Juan Li, Tao Guo Cellular Signalling.2026; 138: 112252. CrossRef
Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells Xixi Zeng, Yanhong Liao, Weiyi Cheng Journal of Gastroenterology and Hepatology.2025; 40(1): 294. CrossRef
Hepatic Stellate Cell TM4SF1 Accelerates Hepatic Fibrosis Progression via Interacting With the Tyrosine Kinase c-Src Shenglu Liu, Peng Tan, Jiatong Chen, Zhiwei Huang, Bingyu Ren, Zhonghao Jiang, Boyuan Gu, Wenhao Yu, Lei Sun, Yingjun Chen, Jian Ruan, Wenguang Fu Cellular and Molecular Gastroenterology and Hepatology.2025; 19(10): 101559. CrossRef
JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway Li Zhang, Yong‐Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong‐Hua Wang, Yu‐Li Wang, Xiu‐Ping Liu, Fa‐Xing Yu, Jian Wu Clinical and Translational Medicine.2024;[Epub] CrossRef
JCAD, a new potential therapeutic target in cholestatic liver disease Byoung Kuk Jang Clinical and Molecular Hepatology.2024; 30(2): 166. CrossRef
Correspondence on Letter regarding “Both liver parenchymal and non-parenchymal cells express JCAD proteins under various circumstances” Byoung Kuk Jang Clinical and Molecular Hepatology.2024; 30(2): 297. CrossRef
Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu Clinical and Molecular Hepatology.2024; 30(2): 279. CrossRef
Background/Aims Disrupted bile acid regulation and accumulation in the liver can contribute to progressive liver damage and fibrosis. However, the effects of bile acids on the activation of hepatic stellate cells (HSCs) remain unclear. This study investigated the effects of bile acids on HSC activation during liver fibrosis, and examined the underlying mechanisms.
Methods The immortalized HSCs, LX-2 and JS-1cells were used for the in vitro study. in vitro, the adeno-associated viruses adeno-associated virus-sh-S1PR2 and JTE-013 were used to pharmacologically inhibit the activity of S1PR2 in a murine model of fibrosis induced by a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet. Histological and biochemical analyses were performed to study the involvement of S1PR2 in the regulation of fibrogenic factors as well as the activation properties of HSCs.
Result s: S1PR2 was the predominant S1PR expressed in HSCs and was upregulated during taurocholic acid (TCA) stimulation and in cholestatic liver fibrosis mice. TCA-induced HSC proliferation, migration and contraction and extracellular matrix protein secretion were inhibited by JTE-013 and a specific shRNA targeting S1PR2 in LX-2 and JS-1 cells. Meanwhile, treatment with JTE-013 or S1PR2 deficiency significantly attenuated liver histopathological injury, collagen accumulation, and the expression of fibrogenesis-associated genes in mice fed a DDC diet. Furthermore, TCAmediated activation of HSCs through S1PR2 was closely related to the yes-associated protein (YAP) signaling pathway via p38 mitogen-activated protein kinase (p38 MAPK).
Conclusions TCA-induced activation of the S1PR2/p38 MAPK/YAP signaling pathways plays a vital role in regulating HSC activation, which might be therapeutically relevant for targeting cholestatic liver fibrosis.
Citations
Citations to this article as recorded by
Ticagrelor attenuates cholestasis-induced liver fibrosis by inhibiting S1PR2-dependent Akt/ERK signaling, NLRP3 inflammasome activation Walaa H. El-Maadawy, Marwa Amer, Amr Mostafa, Abdelrahman A. Hassany, Nesma S. Shafie, Ahmed W. Lethy, Eman El-Ahwany, Ehab Hafiz International Immunopharmacology.2026; 168: 115834. CrossRef
Liver Stiffness Rises Early in MASLD and Drives Inflammation, Lipid Dysmetabolism, and Fibrosis via Piezo1–YAP Mechanotransduction Juan Ma, Ning Xie, Ziwei Wang, Xiru Liang, Yulong Han, Qiang Zhao, Ming Wang, Hongwei Lu, Wanyi Kou, William Alazawi, Jinhai Wang, Lu Li, Ning Liu, Na Liu, Haitao Shi, Feng Xu Advanced Science.2026;[Epub] CrossRef
Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases Lili Ding, Lihua Jin, Wendong Huang Pharmacological Reviews.2026; 78(2): 100115. CrossRef
Gut Microbiome and Bile Acid Metabolism in Liver Disease: Mechanisms, Clinical Implications, and Therapeutic Opportunities Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip.B. Hylemon Pharmacological Reviews.2026; : 100120. CrossRef
Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment Ina Bergheim, Jean Francois Cadranel, Jianguo Chen, Wenxing Ding, Robert Eferl, Carmen Garcia-Ruiz, Hartmut Jaeschke, Firouzeh Kazerouni, Amedeo Lonardo, Derek A. Mann, Nahum Méndez-Sánchez, Camelia Mokhtari, Han Moshage, Chiara Raggi, Pavel Strnad, Oren Exploration of Digestive Diseases.2026;[Epub] CrossRef
Serum-urine metabolic integration via UPLC-QTOF/MS uncovers shared pathway biomarkers for cirrhosis diagnosis Xiaogang Li, Runxi Wang, Hongbing Zhou, Ruixue Li, Hong Chang, Songli Shi Frontiers in Medicine.2026;[Epub] CrossRef
Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome Aya Miyagawa-Hayashino, Tetsuya Imura, Toshiaki Takezawa, Maki Hirai, Saya Shibata, Hiroshi Ogi, Takahiro Tsujikawa, Eiichi Konishi, Olga A. Sukocheva PLOS ONE.2025; 20(1): e0317568. CrossRef
Extracellular vesicles from mesenchymal stem cells improve liver injury in rats with mild liver damage. Underlying mechanisms and role of TGFβ Gergana Mincheva, Victoria Moreno-Manzano, Vicente Felipo, Marta Llansola Life Sciences.2025; 364: 123429. CrossRef
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review) Zhaoyu Li, Lingjun Deng, Mengting Cheng, Xiandong Ye, Nanyan Yang, Zaiwen Fan, Li Sun International Journal of Oncology.2025; 66(3): 1. CrossRef
The impact of sleeve gastrectomy on MASH development by regulating the composition of gut microbiota and metabolic homeostasis Lingxi Ye, Zhenyu Yao, Qiuhui Xuan, Qiaoran Liu, Tao Bo Biochemical and Biophysical Research Communications.2025; 752: 151466. CrossRef
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease Carlo Acierno, Riccardo Nevola, Luca Rinaldi, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Alfredo Caturano Livers.2025; 5(2): 17. CrossRef
A preliminary study of serum metabolomic profiling in male patients with acute brucellosis Shenglian Niu, Qiang Li, Jianling Wang, Jiquan Li, Yanmei Zhao, Hongmei Xue, Li Ma, Zhijun Zhao, Qingwen Zhang Scientific Reports.2025;[Epub] CrossRef
Biological Actions of Bile Acids via Cell Surface Receptors Yoshimitsu Kiriyama, Hiroshi Tokumaru, Hisayo Sadamoto, Hiromi Nochi International Journal of Molecular Sciences.2025; 26(11): 5004. CrossRef
Roles of Bile Acid-Activated Receptors in Monocytes-Macrophages and Dendritic Cells Huilin Jia, Xingli He, Tengfei Jiang, Fanzhi Kong Cells.2025; 14(12): 920. CrossRef
TEAD4-mediated upregulation of LPAR3 augments hepatic stellate cell activation in portal hypertension Ruizhao Qi, Zhengyao Chang, Wenlei Zhao, Yuxuan Qiu, Weihua Chang, Ying Zhang, Xinglong Hu, Zhiwei Li Cell Biology and Toxicology.2025;[Epub] CrossRef
Mac‐2 Binding Protein Glycosylation Isomer (M2BPGi) Increases in Patients With Obstructive Jaundice through the Activation of Hepatic Stellate Cells by Bile Acids Norihiro Ishii, Kenichiro Araki, Dolgormaa Gantumur, Ryosuke Fukushima, Takayuki Okuyama, Takaomi Seki, Haruka Okami, Kei Hagiwara, Kouki Hoshino, Shunsuke Kawai, Mariko Tsukagoshi, Takamichi Igarashi, Norio Kubo, Ken Shirabe Hepatology Research.2025; 55(10): 1376. CrossRef
First-in-class drug oroxylin A tablets for treating hepatic and gastrointestinal disorders: from preclinical development to clinical research Chengju Luo, Xuhong Li, Yuan Gao, Junyi Yang, Weiming Fang, Libin Wei Chinese Journal of Natural Medicines.2025; 23(7): 801. CrossRef
Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis Luping Wang, Yi Huang, Jingrong Chen, Jialu Gao, Sihan Chen, Mingqi Zhao, Jiguo Lin, Shunqing Zhou, Yannan Shen, Yunyun Cheng Frontiers in Cell and Developmental Biology.2025;[Epub] CrossRef
Mac‐2 Binding Protein Glycosylation Isomer as a Dynamic Biomarker in Obstructive Cholestasis Takanobu Iwadare, Takefumi Kimura Hepatology Research.2025; 55(10): 1333. CrossRef
Immunotherapy-induced cholestasis in cancer: insights from the two real-world pharmacovigilance databases of FAERS and VigiBase Xinrong Yan, Zhengrui Li, Aimin Jiang, Jinghong Chen, Xufeng Huang, András Hajdu, Hank Z.H. Wong, Quan Cheng, Jian Zhang, Anqi Lin, Peng Luo International Journal of Surgery.2025; 111(8): 5105. CrossRef
Bile Acid-Mediated Interactions with Various Cell Types in the Cholestatic Liver Guanyi He, Jie Qing DNA and Cell Biology.2025; 44(9): 502. CrossRef
Co-Fermented Black Barley and Quinoa Alleviate Hepatic Inflammation via Regulating Metabolic Disorders and Gut Microbiota in Mice Fed with High-Fat Diet Fenfen Wei, Huibin Jiang, Chuang Zhu, Lingyue Zhong, Zihan Lin, Yan Wu, Lihua Song Nutrients.2025; 17(20): 3228. CrossRef
Regulatory effects of Sini-San on bile acid homeostasis in the enterohepatic circulation of mice with liver fibrosis Fangsi Zhu, Yijie Ding, Luyun Chen, Rou Fang, Chengfeng Huang, En Liu, Yingrui Wang, Yong Su, Chaoliang Ge Chinese Medicine.2025;[Epub] CrossRef
Tibetan medicine Pa Zhu Wan ameliorates carbon tetrachloride-induced liver fibrosis in rats by regulating the TGF-β-Smad2/3 and IL-6/JAK2/STAT3 signaling pathways Linlin Zhao, Yan Jiang, Jing Ma, Yongjing Yang, Guo Liu, Zhengxing Wang, Tin Wui Wong, Dejun Zhang Frontiers in Pharmacology.2025;[Epub] CrossRef
Integrated transcriptomic and metabolomic analyses reveal the pathogenesis of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced liver injury in mice Zijun Zhang, Rong Ji, Ahua Ku, Ruhan A, Binbin Song Toxicology Letters.2025; 414: 111786. CrossRef
Taurocholic Acid Is Associated With Disturbed Functional Connectivity in the Hippocampus of Patients With Depression Xiaoying Cai, Taipeng Sun, Mengzhen Feng, Gang Chen, Junchi Zhou, Hong Zhuang, Dan Wang, Ying Chen, Zhen Cheng, Zhi Xu, Xiao Zheng, Xueli Zhang, Yonggui Yuan Advanced Science.2025;[Epub] CrossRef
Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid Kang Wu, Yi Liu, Jie Xia, Jiale Liu, Kai Wang, Huijun Liang, Fengli Xu, Dina Liu, Dan Nie, Xin Tang, Ailong Huang, Chang Chen, Ni Tang Advanced Science.2024;[Epub] CrossRef
Collaborative Metabolism: Gut Microbes Play a Key Role in Canine and Feline Bile Acid Metabolism John C. Rowe, Jenessa A. Winston Veterinary Sciences.2024; 11(2): 94. CrossRef
Cordycepin alleviates hepatic fibrosis in association with the inhibition of glutaminolysis to promote hepatic stellate cell senescence Zhu Liang, Keyan Zhang, Hongli Guo, Xujiao Tang, Mingzhu Chen, Jinsong Shi, Jing Yang International Immunopharmacology.2024; 132: 111981. CrossRef
S1PR2 participates in intestinal injury in severe acute pancreatitis by regulating macrophage pyroptosis Tianjiao Lin, Mengyuan Peng, Qingyun Zhu, Xinting Pan Frontiers in Immunology.2024;[Epub] CrossRef
Microglia-mediated pericytes migration and fibroblast transition via S1P/S1P3/YAP signaling pathway after spinal cord injury Ziyuan Yu, Huabin Zhang, Linxi Li, Zhi Li, Danmin Chen, Xiao Pang, Yunxiang Ji, Yezhong Wang Experimental Neurology.2024; 379: 114864. CrossRef
Human placental mesenchymal stromal cells promote the formation of CD8+CD122+PD-1+Tregs via CD73/Foxo1 to alleviate liver injury in graft-versus-host disease mice Yaxuan Zhao, Zhenghua Chen, Yunhua Wu, Jiashen Zhang, Hengchao Zhang, Kaiyue Han, Hua Wang, Heng Li, Xiying Luan International Immunopharmacology.2024; 138: 112554. CrossRef
Role of gut/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis Xing-Ming Xie, Shu Feng, Tao Liu, Jun Feng, Yuan Xu, Zi-Jun Fan, Guo-Ying Wang International Immunopharmacology.2024; 139: 112747. CrossRef
Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier Linzhang Zhang, Xiaoyu Jiang, Jiewen Shi, Jianwei Zhang, Xiaoli Shi, Zhishen Xie, Gaofeng Chen, Hua Zhang, Yongping Mu, Jiamei Chen, Shenglan Qi, Ping Liu, Wei Liu Journal of Ethnopharmacology.2024; 335: 118649. CrossRef
Dysregulation of sphingolipid metabolism in liver fibrosis Nan Wu, Meiyi Song, Fan Zhang, Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou Metabolism and Target Organ Damage.2024;[Epub] CrossRef
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development Tiangang Li, John Y.L. Chiang Pharmacological Reviews.2024; 76(6): 1221. CrossRef
Liver fibrosis reflects tissue scarring in the liver due to the accumulation of excessive extracellular matrix in response to chronically persistent liver injury. Hepatocyte cell death can trigger capillarization of liver sinusoidal endothelial cells, stimulation of immune cells including macrophages and Kupffer cells, and activation of hepatic stellate cells (HSCs), resulting in progression of liver fibrosis. Liver cirrhosis is the terminal state of liver fibrosis and is associated with severe complications, such as liver failure, portal hypertension, and liver cancer. Nevertheless, effective therapy for cirrhosis has not yet been established, and liver transplantation is the only radical treatment for severe cases. Studies investigating HSC activation and regulation of collagen production in the liver have made breakthroughs in recent decades that have advanced the knowledge regarding liver fibrosis pathophysiology. In this review, we summarize molecular mechanisms of liver fibrosis and discuss the development of novel anti-fibrotic therapies.
Citations
Citations to this article as recorded by
Roumudan decoction attenuates hepatic fibrosis by suppressing the Warburg effect via inhibiting key glycolytic proteins Meng Pan, Huanyu Li, Hao Guo, Shiting Luo, Jianxuan Yao, Mingxin Zhang, Yang Luo, Xiaoyan Shi Journal of Ethnopharmacology.2026; 356: 120862. CrossRef
Advanced strategies based on nanomedicine for Liver fibrosis treatment Lu Zhang, Tingting Liu, Huan Shen, Boheng Liu, Yun Mei, Yang Liu, Shuo Chen, Xingcong Ma, Chenyang He, Tinghua Hu, Bin Li, Gang Cao, Shuo Yu International Journal of Pharmaceutics.2026; 688: 126437. CrossRef
Salvianolic acid B targets MST1/2-YAP axis to drive phospho-Smad3L/C conversion against hepatocarcinogenesis Wenjing Xu, Yanyan Xu, Shuchen Han, Yuqi Dang, Changfeng Xue, Jingqi Zhou, Shufang He, Yongfang Gong, Yan Yang Phytomedicine.2026; 150: 157655. CrossRef
Modulating MiR-350/Akt/mTOR/beclin1 signaling by nitazoxanide ameliorates bleomycin-induced pulmonary fibrosis in a wistar rat model Eman M. Elbaz, Yara Shawky, Amina A.S. Abdel Rahman, Maha Abdelmonem Life Sciences.2026; 386: 124166. CrossRef
Immune System and Hepatic Stellate Cells’ Crosstalk in Liver Fibrosis: Pathways and Therapeutic Potential Wahyu Widowati, Adilah Hafizha Nur Sabrina, Annisa Firdaus Sutendi, Fadhilah Haifa Zahiroh, Aris Muhamad Nurjamil, Teresa Liliana Wargasetia, Ita Margaretha Nainggolan, Rizal Azis, Elham Rismani, Massoud Vosough, Poorani Gurumallesh Prabu Journal of Immunology Research.2026;[Epub] CrossRef
The Fibrosis-5 Index Predicts Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention Senjiang Chen, Bouwei Zhu, Zan Luo, Yinchao Wang, Qingqing Hu, Liang Zhou Angiology.2025; 76(8): 734. CrossRef
Hepatic antifibrotic effects of bezafibrate in vitro and in vivo models of liver fibrosis Camille Kirinus Reghelin, Matheus Scherer Bastos, Bruno de Souza Basso, Bruna Pasqualotto Costa, Arieli Cruz de Sousa, Bianca Andrade Martha, Géssica Luana Antunes, Marcella Tornquist Nassr, Maria Claudia Rosa Garcia, Lucas Strassburger Matzenbacher, Vito Food and Chemical Toxicology.2025; 200: 115351. CrossRef
Multiomics Analysis and Machine Learning-based Identification of Molecular Signatures for Diagnostic Classification in Liver Disease Types Along the Microbiota-gut-liver Axis Betul Comertpay, Esra Gov Journal of Clinical and Experimental Hepatology.2025; 15(5): 102552. CrossRef
Challenges of in vitro modelling of liver fibrosis Patricia Ros-Tarraga, Estela Villanueva-Badenas, Estela Sanchez-Gonzalez, Gloria Gallego-Ferrer, M. Teresa Donato, Laia Tolosa Frontiers in Cell and Developmental Biology.2025;[Epub] CrossRef
Phosphocreatine alleviates liver fibrosis in diabetic mice by targeting TGF-β/Smad and α-SMA pathways Fu Han Wang, Eskandar Qaed, Waleed Aldahmash, Mueataz A. Mahyoub, Dalal Sanad Al-Mutairi, Zeyao Tang, Marwan almoiliqy Tissue and Cell.2025; 96: 103013. CrossRef
Real-World Experience of Home Continuous Terlipressin Infusion for Complications of Portal Hypertension Brooke Chapman, Marie Sinclair, Avik Majumdar, Catherine Yu, James Widdop, Rudolf Hoermann, Kate Collins, Ryma Terbah, Katrina Tan, Adam Testro American Journal of Gastroenterology.2025;[Epub] CrossRef
Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity Mingjun Lu, Ziqi Dai, Yixuan Lin, Changsheng Sun, Shuo Li, Zhuoqian Guo, Yongji Liu, Xiaobi Liu, Shanlan Li, Runping Liu, Bing Xu, Haimin Lei International Journal of Nanomedicine.2025; Volume 20: 9135. CrossRef
Global, Regional, and National Burden of Chronic Hepatitis B-Related Cirrhosis From 1990 to 2021 and Projections to 2050: A Finding From the Global Burden of Disease Study 2021 Jinyan Sun, Jin Guo Clinical and Translational Gastroenterology.2025; 16(10): e00890. CrossRef
Discovery of novel anti-fibrotics through phenotypic screening Alice R. Lapthorn, Sophie L. Harding-Fox, Kieran M. Feltham, Marcus M. Ilg, Selim Cellek Drug Discovery Today.2025; 30(9): 104450. CrossRef
Shining light on liquid–liquid phase separation in chronic liver disease Ming-Hui Li, Yang Yang, Qi-Qi Dong, Wen-Jie Sun, Hui Tao, Jing-Jing Yang Drug Discovery Today.2025; 30(10): 104464. CrossRef
Tetramethylpyrazine improves the structure and function of mitochondrial-associated endoplasmic reticulum membrane and liver fibrosis Kaihong Xie, Jianzhi Wu, Liping Gong, Wenqing Qin, Zixuan Huo, Yinhao Zhang, Jiaorong Qu, Runping Liu, Jianan Li, Jianhang Lan, Yufei Li, Ranyi Luo, Xiaojiaoyang Li Journal of Advanced Research.2025;[Epub] CrossRef
Design, Synthesis, and Evaluation of Antifibrotic Activity of Nonsteroidal VDR Agonists Featuring 1,6-Naphthol as a CD-Ring Surrogate Yi Gao, Yue Wu, Chun Guan, Nuo Cheng, Yu Tong, Cong Wang, Can Zhang Journal of Medicinal Chemistry.2025; 68(19): 20561. CrossRef
Sublingual Dripping Pill Formulation of Ganoderma amboinense Fruiting Body Extract Attenuates CCl4-Induced Liver Fibrosis via Multi-Pathway Regulation Chin-Feng Liu, Chong-Ming Pan, Chun-Lin Lee Current Issues in Molecular Biology.2025; 47(9): 697. CrossRef
Resveratrol ameliorates liver fibrosis by inhibiting ATF4 to regulate glutamine metabolism in hepatic stellate cells Huiya Ying, Yixiao Wang, Dandan Zhu, Jun Xu, Xiangting Zhang, Hong Pan, Yuan Zeng, Xiao Wu, Weimin Cai, Ruoru Zhou, Ziqiang Xia, Fujun Yu Archives of Pharmacal Research.2025; 48(11-12): 1420. CrossRef
Hepatic Fibrosis and Liver Cancer Aina Anton, Scott L. Friedman, Bruno Cogliati Seminars in Liver Disease.2025;[Epub] CrossRef
Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin Current Drug Therapy.2024; 19(1): 20. CrossRef
An RORα agonist, ODH-08, inhibits fibrogenic activation of hepatic stellate cells via suppression of SMAD3 Haena Choi, Daehyun Oh, Hyeon-Ji Kim, Melody Chambugong, Mi-hyun Kim, Mi-Ock Lee, Hyeung-geun Park Life Sciences.2024; 340: 122443. CrossRef
TNFRSF12A mRNA Expression and Distribution of TNFRSF12A+ Cells in the Rate Liver during Thioacetamide-Induced Fibrogenesis E. I. Lebedeva, A. T. Shchastniy, A. S. Babenka Biology Bulletin.2024; 51(1): 11. CrossRef
RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway Hanlin Shi, Xiaohong Duan, Jingcheng Dong, Yanyan Tao, Yang Lei Journal of Ethnopharmacology.2024; 326: 117963. CrossRef
Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway Xin Wang, Hui Liu, Yuqi Wang, Peng Wang, Yunyun Yi, Yingying Lin, Xin Li Journal of Gastroenterology and Hepatology.2024; 39(7): 1422. CrossRef
The current landscape of antifibrotic therapy across different organs: A systematic approach Isabel Fuster-Martínez, Sara Calatayud Pharmacological Research.2024; 205: 107245. CrossRef
TNFRSF12A mRNA Expression and distribution of TNFRSF12A+ cells in rat liver during thioacetamide-induced fibrogenesis Elena I. Lebedeva, Anatoly T. Shchastniy, Andrei S. Babenka Известия Российской академии наук. Серия биологическая.2024; (1): 14. CrossRef
LOXL2 in non‐alcoholic Steatohepatitis (NASH): Insights into fibrosis pathogenesis and therapeutic potential Joys Rachel Immanuel, Rajnish Kumar, Ashish Kumar Agrahari, Shailendra Asthana Liver International Communications.2024;[Epub] CrossRef
Two-dimensional vascularized liver organoid on extracellular matrix with defined stiffness for modeling fibrotic and normal tissues Lei Ma, Lin Yin, Hai Zhu, Jing Li, Dong Wang Journal of Tissue Engineering.2024;[Epub] CrossRef
Phytotherapeutic approach to enhance the hepatoprotective activity of some edible plants: Molecular docking and nanoformulation Khaled A. Nematallah, Amgad Albohy, Noha Swilam Journal of Functional Foods.2024; 122: 106471. CrossRef
Advances in the understanding of the role and mechanism of action of PFKFB3‑mediated glycolysis in liver fibrosis (Review) Qian Liu, Jiajia Li, Xin Li, Li Zhang, Shun Yao, Yongfeng Wang, Biguang Tuo, Hai Jin International Journal of Molecular Medicine.2024;[Epub] CrossRef
Nitazoxanide mitigates methotrexate hepatotoxicity in rats: role in inhibiting apoptosis and regulating endoplasmic reticulum stress Nevertyty Mohamed Mahmoud, Shimaa M. Elshazly, Fatma El-shaarawy, Sawsan A. Zaitone, Afaf A. Aldahish, Gehan A. Ahmed, Manal S. Fawzy, Sheka Yagub Aloyouni, Sally Y. Abed, Tahani Saeedi, Shaimaa S. El-Sayed Frontiers in Pharmacology.2024;[Epub] CrossRef
Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study Yoonseok Lee, Seryun Bae, Ji Hoon Kim, Minjung Kwak, So Yeon Jeon, Taehyung Kim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun Journal of Clinical Medicine.2023; 12(2): 712. CrossRef
Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist Mitsutaka Nakashima, Kazufumi Nakamura, Takahiro Nishihara, Keishi Ichikawa, Rie Nakayama, Yoichi Takaya, Norihisa Toh, Satoshi Akagi, Toru Miyoshi, Teiji Akagi, Hiroshi Ito Nutrients.2023; 15(3): 748. CrossRef
Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials Jihyun An, Joo Hyun Sohn Clinical and Molecular Hepatology.2023; 29(Suppl): S268. CrossRef
Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells Qiuyun Yi, Jinxian Yang, Ying Wu, Ying Wang, Qiqi Cao, Wen Wen Frontiers in Immunology.2023;[Epub] CrossRef
Hydronidone ameliorates liver fibrosis by inhibiting activation of hepatic stellate cells via Smad7‐mediated degradation of TGFβRI Xianjun Xu, Yuecheng Guo, Xin Luo, Zhenyang Shen, Zhongshang Sun, Bo Shen, Cui Zhou, Junjun Wang, Jingyi Lu, Qingqing Zhang, Yanping Ye, Ying Luo, Ying Qu, Xiaobo Cai, Hui Dong, Lungen Lu Liver International.2023; 43(11): 2523. CrossRef
Hepatoprotective Effect of Medicine Food Homology Flower Saffron against CCl4-Induced Liver Fibrosis in Mice via the Akt/HIF-1α/VEGF Signaling Pathway Huajuan Jiang, Xulong Huang, Jiaxin Wang, Yongfeng Zhou, Chaoxiang Ren, Tao Zhou, Jin Pei Molecules.2023; 28(21): 7238. CrossRef
Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches Omima S. Mohammed, Hany G. Attia, Bassim M. S. A. Mohamed, Marawan A. Elbaset, Hany M. Fayed Journal of Pharmacy & Pharmaceutical Sciences.2023;[Epub] CrossRef
A Unique Immune-Related Gene Signature Represents Advanced Liver Fibrosis and Reveals Potential Therapeutic Targets Pil-Soo Sung, Chang-Min Kim, Jung-Hoon Cha, Jin-Young Park, Yun-Suk Yu, Hee-Jung Wang, Jin-Kyeoung Kim, Si-Hyun Bae Biomedicines.2022; 10(1): 180. CrossRef
Stanniocalcin 1 is a serum biomarker and potential therapeutic target for HBV‐associated liver fibrosis Kristy Kwan‐Shuen Chan, Tsz‐Chun Hon, Kwan‐Yung Au, Hiu‐Lam Choi, Danny Ka‐Ho Wong, Albert Chi‐Yan Chan, Man‐Fung Yuen, Ching‐Lung Lai, Regina Cheuk‐Lam Lo The Journal of Pathology.2022; 257(2): 227. CrossRef
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities Eleonora Binatti, Alessio Gerussi, Donatella Barisani, Pietro Invernizzi International Journal of Molecular Sciences.2022; 23(12): 6649. CrossRef
Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis Yun-Kai Dai, Zhi-Min Zhao, Chenghai Liu Frontiers in Pharmacology.2022;[Epub] CrossRef
The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology Youngseok Lee, Jong-Hoon Kim Clinical and Molecular Hepatology.2022; 28(4): 706. CrossRef
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen Clinical and Molecular Hepatology.2022; 28(4): 841. CrossRef
Multiplexed Digital Spatial Protein Profiling Reveals Distinct Phenotypes of Mononuclear Phagocytes in Livers with Advanced Fibrosis Jaejun Lee, Chang Min Kim, Jung Hoon Cha, Jin Young Park, Yun Suk Yu, Hee Jung Wang, Pil Soo Sung, Eun Sun Jung, Si Hyun Bae Cells.2022; 11(21): 3387. CrossRef
Hepatic HRC induces hepatocyte pyroptosis and HSCs activation via NLRP3/caspase-1 pathway Jingwen Wu, Mingyu Zhang, Suhong Xia, Ping Han, Kai Zhao, Kaixin Peng, Wangdong Zhou, Dean Tian, Jiazhi Liao, Jingmei Liu Journal of Molecular Medicine.2022; 100(12): 1787. CrossRef
Myofibroblast specific targeting approaches to improve fibrosis treatment Elfa Beaven, Raj Kumar, Himanshu N. Bhatt, Stephanie V. Esquivel, Md Nurunnabi Chemical Communications.2022; 58(98): 13556. CrossRef
Multiplexed Digital Spatial Protein Profiling Reveals a Unique Protein Signature for Advanced Liver Fibrosis Jaejun Lee, Chang Min Kim, Jung Hoon Cha, Jin Young Park, Yun Suk Yu, Hee Jung Wang, Pil Soo Sung, Eun Sun Jung, Si Hyun Bae SSRN Electronic Journal .2022;[Epub] CrossRef
Protective Effect of Oligonol on Dimethylnitrosamine-Induced Liver Fibrosis in Rats via the JNK/NF-κB and PI3K/Akt/Nrf2 Signaling Pathways Changyong Lee, Jeonghyeon Bak, Sik Yoon, Jeon-Ok Moon Antioxidants.2021; 10(3): 366. CrossRef
Cytoglobin (Cygb), a stellate cell-specific globin, has recently drawn attention due to its association with liver fibrosis. In the livers of both humans and rodents, Cygb is expressed only in stellate cells and can be utilized as a marker to distinguish stellate cells from hepatic fibroblast-derived myofibroblasts. Loss of Cygb accelerates liver fibrosis and cancer development in mouse models of chronic liver injury including diethylnitrosamine-induced hepatocellular carcinoma, bile duct ligation-induced cholestasis, thioacetamide-induced hepatic fibrosis, and choline-deficient L-amino acid-defined diet-induced non-alcoholic steatohepatitis. This review focuses on the history of research into the role of reactive oxygen species and nitrogen species in liver fibrosis and discusses the current perception of Cygb as a novel radical scavenger with an emphasis on its role in hepatic stellate cell activation and fibrosis.
Citations
Citations to this article as recorded by
Therapeutic potency and the related mechanism of deinoxanthin in experimental animal and cell models of periodontitis Govinda Bhattarai, Yu-Hyeon An, Saroj Kumar Shrestha, Shankar Rijal, Seung-Moon Park, Sung-Ho Kook, Jeong-Chae Lee, Young-Mi Jeon Scientific Reports.2026;[Epub] CrossRef
Combined quercetin with phosphodiesterase inhibitors; sildenafil and pentoxifylline alleviated CCl4-induced chronic hepatic fibrosis: Role of redox-sensitive pathways Gehad Nasr, Doaa Mohamed Elroby Ali, Michael A. Fawzy, Fares E.M. Ali, Moustafa Fathy Food and Chemical Toxicology.2025; 201: 115442. CrossRef
Involvement of IL‐6/JAK/STAT3/SOCS3, SIRT1, and Cytoglobin Signaling in Diacerein Protective Effect against Intestinal Injury Induced by Methotrexate Gaber F. Ali, Emad H. M. Hassanein, Mustafa Ahmed Abdel‐Reheim, El‐shaimaa A. Arafa, Wafaa R. Mohamed Journal of Biochemical and Molecular Toxicology.2025;[Epub] CrossRef
Sexual dimorphism in zebrafish liver proteins and implications for hepatic regeneration and diseases Hamid Niksirat, Kifayatullah Mengal, Golara Kor, Christoph Steinbach, Fredrik Levander Scientific Reports.2025;[Epub] CrossRef
Transcriptomics of a cytoglobin knockout mouse: Insights from hepatic stellate cells and brain Elena Porto, Joey De Backer, Le Thi Thanh Thuy, Norifumi Kawada, Thomas Hankeln Journal of Inorganic Biochemistry.2024; 250: 112405. CrossRef
Albiflorin ameliorates thioacetamide-induced hepatic fibrosis: The involvement of NURR1-mediated inflammatory signaling cascades in hepatic stellate cells activation Jian Song, Bo-Feng Qin, Qi-Yuan Feng, Jin-Jin Zhang, Gui-Yun Zhao, Zheng Luo, Hai-Ming Sun Ecotoxicology and Environmental Safety.2024; 276: 116334. CrossRef
Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery Lixing Xu, Jie Yang, Xinyu Cao, Jiayi Chen, Zhikuan Liu, Liangliang Cai, Yanyan Yu, Haiqin Huang International Journal of Pharmaceutics.2024; 664: 124607. CrossRef
Developing an RNA Signature for Radiation Injury Using a Human Liver-on-a-Chip Model Shannon Martello, Yuki Ueda, Michelle A. Bylicky, Jonathan Pinney, Juan Dalo, Kevin M. K. Scott, Molykutty J. Aryankalayil, C. Norman Coleman Radiation Research.2024;[Epub] CrossRef
The Cytoglobin Expression Under Hypoxic Conditions in Covid-19 Cases Endah Wulandari, Rr Ayu Fitri Hapsari, Francisca A Tjakradidjaja, Alfiah, Auliyani Andam Suri The Open Biomarkers Journal.2023;[Epub] CrossRef
Hypericum perforatum L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties Ala Mohagheghzadeh, Parmis Badr, Abdolali Mohagheghzadeh, Shiva Hemmati Pharmaceuticals.2023; 16(6): 887. CrossRef
Insights into the function of cytoglobin Brandon J. Reeder Biochemical Society Transactions.2023; 51(5): 1907. CrossRef
Functional study of Cygb in the immune response to Vibrio harveyi disease in yellow drum (Nibea albiflora) Shihao Zhou, Oianqian Tian, Wanbo Li, Jiacheng Li, Wenjing Li, Fang Han Fish & Shellfish Immunology.2023; 143: 109217. CrossRef
Role of cytoglobin in cigarette smoke constituent-induced loss of nitric oxide bioavailability in vascular smooth muscle cells Elsayed M. Mahgoup, Sahar A. Khaleel, Mohamed A. El-Mahdy, Adel R. Abd-Allah, Jay L. Zweier Nitric Oxide.2022; 119: 9. CrossRef
Oxidative Stress in Non-Alcoholic Fatty Liver Disease Carlo Smirne, Eleonora Croce, Davide Di Benedetto, Vincenzo Cantaluppi, Cristoforo Comi, Pier Paolo Sainaghi, Rosalba Minisini, Elena Grossini, Mario Pirisi Livers.2022; 2(1): 30. CrossRef
Taurine attenuated methotrexate-induced intestinal injury by regulating NF-κB/iNOS and Keap1/Nrf2/HO-1 signals Emad H.M. Hassanein, Hanan S. Althagafy, Ahmed M. Atwa, Magy R. Kozman, Mohamed.I. Kotb El-Sayed, Ayman A. Soubh Life Sciences.2022; 311: 121180. CrossRef
The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD Ting Hong, Yiyan Chen, Xiaoying Li, Yan Lu, Jun Pu Oxidative Medicine and Cellular Longevity.2021;[Epub] CrossRef
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh International Journal of Molecular Sciences.2021; 22(9): 4495. CrossRef
Anti-fibrotic treatments for chronic liver diseases: The present and the future Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada Clinical and Molecular Hepatology.2021; 27(3): 413. CrossRef
Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver Erika Ramos-Tovar, Pablo Muriel Antioxidants.2020; 9(12): 1279. CrossRef
Background/Aims This study aimed to better understand gene expression profiles of human hepatic stellate cell (HSC) activation and the relationship with the Wnt signaling pathway. Methods: The global transcript levels in platelet derived growth factor-BB (PDGF-BB)-stimulated hTERT HSCs were analyzed using oligonucleotide microarrays. Oligonucleotide microarrays with 19K human oligo chips were performed to obtain gene expression profiles associated with proliferation in human hTERT HSCs. The microarray data was verified by real time quantitative PCR and expression of the components of Wnt signaling was analyzed by Western blot. Results: Microarray data showed 243 up-regulated and 265 down-regulated genes in PDGF-BB-treated HSCs. The changes in expression of glypican3 and BH3 interacting domain death agonist (BID) mRNA in real time quantitative PCR, especially among the highly up- or down-regulated genes, were statistically consistent with the microarray data. The Wnt signaling pathway components, frizzled10 (FZD10) and calcium/calmodulin-dependent protein kinase II alpha (CAMK2A), showed increased expression in the short time course microarray and the up-regulation of FZD10 also occurred at the protein level. Our data showed various gene expression profiles during activation of human HSC. Conclusions: The up-regulated expression of FZD10 and CAMK2A suggests that the Wnt/Ca2+ signaling pathway is active in hTERT HSCs and may participate in HSC activation and proliferation. (Korean J Hepatol 2009;15:486-495)
Citations
Citations to this article as recorded by
Growth Factors and Neuroglobin in Astrocyte Protection Against Neurodegeneration and Oxidative Stress Ricardo Cabezas, Eliana Baez-Jurado, Oscar Hidalgo-Lanussa, Valentina Echeverria, Ghulam Md Ashrad, Amirhossein Sahebkar, George E. Barreto Molecular Neurobiology.2019; 56(4): 2339. CrossRef
Incorporation of Fucoidan in β-Tricalcium phosphate-Chitosan scaffold prompts the differentiation of human bone marrow stromal cells into osteogenic lineage Subramaniam Puvaneswary, Hanumantharao Balaji Raghavendran, Sepehr Talebian, Malliga Raman Murali, Suhaeb A Mahmod, Simmrat Singh, Tunku Kamarul Scientific Reports.2016;[Epub] CrossRef
Herbal medicine Gan-fu-kang downregulates Wnt/Ca2+ signaling to attenuate liver fibrogenesis in vitro and in vivo YUJIE JIA, LIJUN YUAN, TINGTING XU, HANSHU LI, GUANG YANG, MIAONA JIANG, CAIHUA ZHANG, CONG LI Molecular Medicine Reports.2016; 13(6): 4705. CrossRef
First
Prev
